Hematopoietic Stem Cell Transplantation for Multiple Myeloma
- PMID: 28729120
- DOI: 10.1016/j.soncn.2017.05.004
Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Abstract
Objective: To provide an overview of the hematopoietic stem cell transplantation (HSCT) process specific to patients with multiple myeloma (MM) and their caregivers.
Data sources: Research studies, book chapters, websites, expert knowledge, and journal articles.
Conclusion: Although not curative, autologous HSCT is an important, manageable treatment modality, and continues to be a standard of care in MM for those patients who are eligible.
Implications for nursing practice: Although an area of specialty practice, an understanding of the HSCT process is important to broaden the knowledge of all nurses who care for patients with MM.
Keywords: caregivers; hematopoietic stem cell transplantation; multiple myeloma; resources; treatment.
Copyright © 2017 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical